Short Stature Syndromes: Case Series from India

Abstract

Syndromes causing short stature include Noonan syndrome (NS), Williams syndrome, and Silver–Russell syndrome (SRS). SRS is a primordial dwarfism with genetic heterogeneity. The SRS children present with prenatal growth retardation, neonatal hypoglycemia, feeding difficulties, physical asymmetry, with scoliosis and cardiac defect in some cases. The incidence is up to 1 in 100,000. Uniparental disomy, methylation abnormalities, and variants in some genes have been found underlying such phenotype. Growth hormone therapy has been used to improve the height gain in these patients. NS has genetic heterogeneity and most patients present with short stature with or without cardiac defect. Multiple genetic variants, mostly autosomal dominant, contribute to the phenotype. With the availability of next-generation sequencing, more and more genetic disorders causing short stature are being identified in different ethnic populations like Kabuki syndrome and Nance–Horan syndrome. Here, we present some cases of SRS and other additional syndromes with dysmorphism seen in past 5 years.

Keywords

Noonan syndrome - Kabuki syndrome - Silver–Russell syndrome - MLPA - NGS

• References

• 1 Wakeling EL, Brioude F, Lokulo-Sodipe O. et al. Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol 2017; 13 (02) 105-124
• 2 Khetarpal P, Das S, Panigrahi I, Munshi A. Primordial dwarfism: overview of clinical and genetic aspects. Mol Genet Genomics 2016; 291 (01) 1-15
• 3 Inoue T, Nakamura A, Iwahashi-Odano M. et al. Contribution of gene mutations to Silver-Russell syndrome phenotype: multigene sequencing analysis in 92 etiology-unknown patients. Clin Epigenetics 2020; 12 (01) 86
• 4 van der Burgt I, Berends E, Lommen E, van Beersum S, Hamel B, Mariman E. Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet 1994; 53 (02) 187-191
• 5 Romano AA, Allanson JE, Dahlgren J. et al. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics 2010; 126 (04) 746-759
• 6 Sharma S, Ang SL, Shaw M. et al. Nance-Horan syndrome protein, NHS, associates with epithelial cell junctions. Hum Mol Genet 2006; 15 (12) 1972-1983
• 7 Schwartz CE, Gillessen-Kaesbach G, May M. et al. Two novel mutations confirm FGD1 is responsible for the Aarskog syndrome. Eur J Hum Genet 2000; 8 (11) 869-874
• 8 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 9 Azzi S, Salem J, Thibaud N. et al. A prospective study validating a clinical scoring system and demonstrating phenotypical-genotypical correlations in Silver-Russell syndrome. J Med Genet 2015; 52 (07) 446-453
• 10 Malaquias AC, Noronha RM, Souza TTO. et al. Impact of growth hormone therapy on adult height in patients with PTPN11 mutations related to Noonan syndrome. Horm Res Paediatr 2019; 91 (04) 252-261
• 11 Priolo M, Sparago A, Mammì C, Cerrato F, Laganà C, Riccio A. MS-MLPA is a specific and sensitive technique for detecting all chromosome 11p15.5 imprinting defects of BWS and SRS in a single-tube experiment. Eur J Hum Genet 2008; 16 (05) 565-571
• 12 Online Mendelian Inheritance in Man. OMIM. McKusick-Nathans Institute of Genetic Medicine, John Hopkins University (Baltimore, MD). Accessed February 17, 2021 at: https://omim.org/
• 13 Celli J, van Bokhoven H, Brunner HG. Feingold syndrome: clinical review and genetic mapping. Am J Med Genet A 2003; 122A [phone]
• 14 Shaw-Smith C. Oesophageal atresia, tracheo-oesophageal fistula, and the VACTERL association: review of genetics and epidemiology. J Med Genet 2006; 43 (07) 545-554
• 15 Bedoyan JK, Friez MJ, DuPont B, Ahmad A. First case of deletion of the faciogenital dysplasia 1 (FGD1) gene in a patient with Aarskog-Scott syndrome. Eur J Med Genet 2009; 52 (04) 262-264
• 16 Ramprasad VL, Thool A, Murugan S. et al. Truncating mutation in the NHS gene: phenotypic heterogeneity of Nance-Horan syndrome in an asian Indian family. Invest Ophthalmol Vis Sci 2005; 46 (01) 17-23
• 17 Shaheen R, Faqeih E, Ansari S. et al. Genomic analysis of primordial dwarfism reveals novel disease genes. Genome Res 2014; 24 (02) 291-299
• 18 Guo C, Nakazawa Y, Woodbine L. et al. XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiency. J Allergy Clin Immunol 2015; 136 (04) 1007-1017
• 19 Adam MP, Banka S, Bjornsson HT. et al; Kabuki Syndrome Medical Advisory Board. Kabuki syndrome: international consensus diagnostic criteria. J Med Genet 2019; 56 (02) 89-95
• 20 Margot H, Boursier G, Duflos C. et al. Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals. Genet Med 2020; 22 (01) 181-188
• 21 Digilio MC, Gnazzo M, Lepri F. et al. Congenital heart defects in molecularly proven Kabuki syndrome patients. Am J Med Genet A 2017; 173 (11) 2912-2922
• 22 Kumari D, Chaudhary D, Panigrahi I, Rohit MK. Genetic defects in children with cardiac anomalies/malformations. Noonan and CFC syndromes. J Pediatr Genet 2020. DOI: 10.1055/s-0040-1721441
• 23 Panigrahi I, Angurana SK, Varma H. et al. Phenotypic heterogeneity of kyphoscoliosis with vertebral and rib defects: a case series. Clin Dysmorphol 2019; 28 (03) 103-113
• 24 Yu Y, Yao R, Wang L. et al. De novo mutations in ARID1B associated with both syndromic and non-syndromic short stature. BMC Genomics 2015; 16 (01) 701
• 25 Bögershausen N, Gatinois V, Riehmer V. et al. Mutation update for Kabuki syndrome genes KMT2D and KDM6A and further delineation of X-linked Kabuki syndrome subtype 2. Hum Mutat 2016; 37 (09) 847-864